Temat: "falciparum" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Distribution patterns of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates on the Thai-Myanmar border during the periods of 1993-1998 and 2002-2008.
Autorzy:: Muhamad P; Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathumthani, 12120, Thailand.
Phompradit P; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand.
Chaijaroenkul W; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand.; Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand.; Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand.
Na-Bangchang K; Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathumthani, 12120, Thailand. .; Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand. .; Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand. .; Graduate Program in Bioclinical Sciences, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, 12120, Thailand. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Mar 11; Vol. 25 (1), pp. 269. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/genetics
Humans ; Plasmodium falciparum ; Thailand ; Myanmar ; Multidrug Resistance-Associated Proteins/genetics ; Drug Resistance/genetics ; Real-Time Polymerase Chain Reaction ; Biomarkers ; Protozoan Proteins/genetics ; Codon

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in mainland Tanzania, 2018.
Autorzy:: Ngasala B; Department of Parasitology, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania. .
Chiduo MG; Tanga Research Centre, National Institute for Medical Research, P.O Box 5004, Tanga, Tanzania.
Bushukatale S; Department of Parasitology, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Mmbando BP; Tanga Research Centre, National Institute for Medical Research, P.O Box 5004, Tanga, Tanzania.
Makene T; Department of Parasitology, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Kamugisha E; Catholic University of Health and Allied Sciences/Bugando Medical Centre, P. O Box 1464, Mwanza, Tanzania.
Ahmed M; Catholic University of Health and Allied Sciences/Bugando Medical Centre, P. O Box 1464, Mwanza, Tanzania.
Mandara CI; Tanga Research Centre, National Institute for Medical Research, P.O Box 5004, Tanga, Tanzania.; National Institute for Medical Research, Headquarters, P.O. Box 9653, Dar-es-Salaam, Tanzania.
Francis F; Tanga Research Centre, National Institute for Medical Research, P.O Box 5004, Tanga, Tanzania.
Mahende MK; Ifakara Health Institute Dar es Salaam Office, P. O. Box 78373, Dar es Salaam, Tanzania.
Kavishe RA; Kilimanjaro Christian Medical Centre, P.O. Box 3010, Moshi, Tanzania.
Muro F; Kilimanjaro Christian Medical Centre, P.O. Box 3010, Moshi, Tanzania.
Ishengoma DS; National Institute for Medical Research, Headquarters, P.O. Box 9653, Dar-es-Salaam, Tanzania.
Mandike R; National Malaria Control Programme (NMCP), P.O. Box 743, Dodoma, Tanzania.
Molteni F; National Malaria Control Programme (NMCP), P.O. Box 743, Dodoma, Tanzania.
Chacky F; National Malaria Control Programme (NMCP), P.O. Box 743, Dodoma, Tanzania.
Kitojo C; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Greer G; U.S. President's Malaria Initiative, U.S. Agency for International Development, Dar es Salaam, Tanzania.
Bishanga D; Department of Community Health, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Chadewa J; Jhpiego, Boresha Afya, P.O. Box 9170, Dar es Salaam, Tanzania.
Njau R; World Health Organization Country Office, P.O Box 9292, Dar es Salaam, Tanzania.
Warsame M; Gothenburg University, Gothenburg, Sweden.
Kabula B; RTI International, Dar es Salaam, Tanzania.
Nyinondi SS; RTI International, Dar es Salaam, Tanzania.
Reaves E; U.S. President's Malaria Initiative, U.S. Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
Mohamed A; National Malaria Control Programme (NMCP), P.O. Box 743, Dodoma, Tanzania.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 06; Vol. 23 (1), pp. 95. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/adverse effects
Artemisinins*/adverse effects
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/prevention & control
Malaria*/drug therapy
Child ; Humans ; Artemether, Lumefantrine Drug Combination/adverse effects ; Tanzania ; Reinfection/chemically induced ; Reinfection/drug therapy ; Artemether/therapeutic use ; Amodiaquine/therapeutic use ; Fever/drug therapy ; Drug Combinations ; Ethanolamines/adverse effects ; Plasmodium falciparum

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Autorzy:: Dorkenoo AM; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo. .
Warsame M; School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Ataba E; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Hemou M; Service de Pédiatrie, Centre Hospitalier Universitaire Campus, Lomé, Togo.
Yakpa K; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Sossou E; Service des Laboratoires, Centre Hospitalier Universitaire Sylvanus Olympio Lomé, Lomé, Togo.
Mitigmsagou M; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Teou CD; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Caspar E; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.
Ma L; Biomics Platform, C2RT, Institut Pasteur, 75015, Paris, France.
Djadou KE; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Atcha-Oubou T; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Rasmussen C; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Menard D; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.; Malaria Genetics and Resistance Unit, Institut Pasteur, Université Paris Cité, INSERM U1201, 75015, Paris, France.; Malaria Parasite Biology and Vaccines, Institut Pasteur, Université Paris Cité, 75015, Paris, France.; Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, 67000, Strasbourg, France.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 03; Vol. 23 (1), pp. 92. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Quinolines*/pharmacology
Quinolines*/therapeutic use
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/parasitology
Malaria*/drug therapy
Piperazines*
Artemisinins*
Child ; Adult ; Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether, Lumefantrine Drug Combination/pharmacology ; Prevalence ; Togo/epidemiology ; Prospective Studies ; Artemether/therapeutic use ; Drug Resistance ; Tetrahydrofolate Dehydrogenase/genetics ; Biomarkers ; Drug Combinations ; Plasmodium falciparum/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania.
Autorzy:: Ishengoma DS; National Institute for Medical Research, Dar es Salaam, Tanzania. .; Faculty of Pharmaceutical Sciences, Monash University, Melbourne, Australia. .; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA. .
Mandara CI; National Institute for Medical Research, Dar es Salaam, Tanzania.
Madebe RA; National Institute for Medical Research, Dar es Salaam, Tanzania.
Warsame M; Gothenburg University, Gothenburg, Sweden.
Ngasala B; Department of Parasitology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Department of Women's and Children's Health, International Maternal and Child Health (IMCH), Uppsala University, Uppsala, Sweden.
Kabanywanyi AM; Ifakara Health Institute, Dar es Salaam, Tanzania.
Mahende MK; Ifakara Health Institute, Dar es Salaam, Tanzania.
Kamugisha E; Bugando Medical Centre, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Kavishe RA; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Muro F; Kilimanjaro Christian Medical Centre, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Mandike R; National Malaria Control Programme, Ministry of Health, Dodoma, Tanzania.
Mkude S; National Malaria Control Programme, Ministry of Health, Dodoma, Tanzania.
Chacky F; National Malaria Control Programme, Ministry of Health, Dodoma, Tanzania.
Njau R; Malariologist and Public Health Specialist, Dar es Salaam, Tanzania.
Martin T; HIV Vaccine Trials Network, Fred Hutch Cancer Research Centre, Seattle, WA, USA.
Mohamed A; National Malaria Control Programme, Ministry of Health, Dodoma, Tanzania.
Bailey JA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.
Fola AA; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI, USA.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Mar 15; Vol. 23 (1), pp. 79. Date of Electronic Publication: 2024 Mar 15.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Malaria, Falciparum*/parasitology
Humans ; Protozoan Proteins/metabolism ; Genetic Variation ; Tanzania ; Merozoite Surface Protein 1/genetics ; Plasmodium falciparum/genetics ; Plasmodium falciparum/metabolism ; Genotype ; Microsatellite Repeats ; Antigens, Protozoan/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021.
Autorzy:: Bakari C; National Institute for Medical Research, Dar Es Salaam, Tanzania.; Swiss Tropical and Public Health Institute, Basel, Switzerland.
Mandara CI; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Madebe RA; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Seth MD; National Institute for Medical Research, Dar Es Salaam, Tanzania.
Ngasala B; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Kamugisha E; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Ahmed M; Catholic University of Health and Allied Sciences, Bugando Medical Centre, Mwanza, Tanzania.
Francis F; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Bushukatale S; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Chiduo M; National Institute for Medical Research, Tanga Research Centre, Tanga, Tanzania.
Makene T; Department of Parasitology, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Kabanywanyi AM; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.
Mahende MK; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.
Kavishe RA; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Muro F; Kilimanjaro Christian Medical Centre, Moshi, Tanzania.
Mkude S; National Malaria Control Program, Dodoma, Tanzania.
Mandike R; National Malaria Control Program, Dodoma, Tanzania.
Molteni F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; National Malaria Control Program, Dodoma, Tanzania.
Chacky F; National Malaria Control Program, Dodoma, Tanzania.
Bishanga DR; Ifakara Health Institute, Dar Es Salaam Office, Dar Es Salaam, Tanzania.; Maternal and Child Survival Program, Jhpiego, Dar Es Salaam, Tanzania.; School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
Njau RJA; Malariologist and Public Health Specialist, Dar Es Salaam, Tanzania.
Warsame M; University of Gothenburg, Gothenburg, Sweden.
Kabula B; PMI/Okoa Maisha Dhibiti Malaria, RTI International, Dar Es Salaam, Tanzania.; National Institute for Medical Research, Amani Research Centre, Muheza, Tanga, Tanzania.
Nyinondi SS; PMI/Okoa Maisha Dhibiti Malaria, RTI International, Dar Es Salaam, Tanzania.
Lucchi NW; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.; Division of Global Health Protection, U.S. Centers for Disease Control and Prevention, Nairobi, Kenya.
Talundzic E; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Venkatesan M; U.S. President's Malaria Initiative, USAID, Washington, DC, USA.
Moriarty LF; Malaria Branch, U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Serbantez N; U.S. President's Malaria Initiative, USAID, Dar Es Salaam, Tanzania.
Kitojo C; U.S. President's Malaria Initiative, USAID, Dar Es Salaam, Tanzania.
Reaves EJ; U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Dar Es Salaam, Tanzania.
Halsey ES; Malaria Branch, U.S. President's Malaria Initiative, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mohamed A; National Malaria Control Program, Dodoma, Tanzania.
Udhayakumar V; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.; Independenant Consultant, Decatur, Georgia.
Ishengoma DS; National Institute for Medical Research, Dar Es Salaam, Tanzania. .; Faculty of Pharmaceutical Sciences, Monash University, Melbourne, Australia. .; Harvard T.H Chan School of Public Health, Harvard University, Boston, MA, USA. .; Department of Biochemistry, Kampala International University, Dar Es Salaam, Tanzania. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Mar 09; Vol. 23 (1), pp. 71. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Artemisinins*/pharmacology
Artemisinins*/therapeutic use
Malaria, Falciparum*/epidemiology
Carubicin/*analogs & derivatives
Humans ; Lumefantrine/pharmacology ; Lumefantrine/therapeutic use ; Plasmodium falciparum/genetics ; Tanzania ; Artemether/therapeutic use ; Multidrug Resistance-Associated Proteins/genetics ; Artemether, Lumefantrine Drug Combination/pharmacology ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Biomarkers ; Drug Resistance/genetics ; Protozoan Proteins/genetics ; Protozoan Proteins/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Plasmodium falciparum genetic diversity and multiplicity of infection based on msp-1, msp-2, glurp and microsatellite genetic markers in sub-Saharan Africa: a systematic review and meta-analysis.
Autorzy:: Mwesigwa A; Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda. .; Department of Microbiology and Immunology, School of Medicine, Kabale University, P. O Box 314, Kabale, Uganda. .
Ocan M; Department of Pharmacology and Therapeutics, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.; African Center for Systematic Reviews and Knowledge Translation, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Musinguzi B; Departent of Medical Laboratory Science, Faculty of Health Sciences, Muni University, P.O Box 725, Arua, Uganda.
Nante RW; African Center for Systematic Reviews and Knowledge Translation, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Nankabirwa JI; Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.; Infectious Diseases Research Collaboration, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Kiwuwa SM; Department of Biochemistry, School of Biomedical Sciences, College of Health Sciences, Makerere, University, P.O. Box 7072, Kampala, Uganda.
Kinengyere AA; Albert Cook Library, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Castelnuovo B; Infectious Diseases Institute, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.
Karamagi C; Clinical Epidemiology Unit, School of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.
Obuku EA; Infectious Diseases Institute, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.; African Center for Systematic Reviews and Knowledge Translation, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Nsobya SL; Infectious Diseases Research Collaboration, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
Mbulaiteye SM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, 6E-118, Bethesda, MD, 20892, USA.
Byakika-Kibwika P; Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.; Infectious Diseases Institute, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala, Uganda.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 08; Vol. 23 (1), pp. 97. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Merozoite Surface Protein 1*/genetics
Malaria, Falciparum*/parasitology
Humans ; Plasmodium falciparum ; Antigens, Protozoan/genetics ; Protozoan Proteins/genetics ; Genetic Markers ; Genetic Variation ; Genotype ; Alleles ; Microsatellite Repeats ; South Africa

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Rapid and non-invasive detection of malaria parasites using near-infrared spectroscopy and machine learning.
Autorzy:: Sikulu-Lord MT; School of the Environment, Faculty of Science, The University of Queensland, Brisbane, Queensland, Australia.
Edstein MD; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Queensland, Australia.
Goh B; School of the Environment, Faculty of Science, The University of Queensland, Brisbane, Queensland, Australia.
Lord AR; Centre for Data Science, Queensland University of Technology, Brisbane, Queensland, Australia.
Travis JA; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Queensland, Australia.
Dowell FE; Center for Grain and Animal Health Research, USDA Agricultural Research Service, Manhattan, Kansas, United States of America.
Birrell GW; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Queensland, Australia.
Chavchich M; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Queensland, Australia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 25; Vol. 19 (3), pp. e0289232. Date of Electronic Publication: 2024 Mar 25 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Parasites*
Malaria, Falciparum*/diagnosis
Malaria, Falciparum*/parasitology
Malaria*/diagnosis
Animals ; Mice ; Spectroscopy, Near-Infrared/methods ; Plasmodium falciparum ; Machine Learning ; Sensitivity and Specificity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Classification and clinical significance of immunogenic cell death-related genes in Plasmodium falciparum infection determined by integrated bioinformatics analysis and machine learning.
Autorzy:: Zhang YH; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China. .
Xie LH; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.
Li J; State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.
Qi YW; Department of Pathogenic Biology and Immunology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.
Shi JJ; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 15; Vol. 23 (1), pp. 48. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Journal Article
MeSH Terms:: Immunogenic Cell Death*
Malaria, Falciparum*/genetics
Humans ; Clinical Relevance ; Plasmodium falciparum/genetics ; Cross-Sectional Studies ; Computational Biology ; Machine Learning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Enhancing malaria detection in resource-limited areas: A high-performance colorimetric LAMP assay for Plasmodium falciparum screening.
Autorzy:: Nguyen TK; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Jun H; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Louis JM; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Mazigo E; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Lee WJ; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Youm HC; Noul Co., Ltd., Yongin, Gyeonggi-do, Republic of Korea.
Shin J; Noul Co., Ltd., Yongin, Gyeonggi-do, Republic of Korea.
Lungu DK; Wezi Medical Centre, Mzuzu, Malawi.
Kanyemba C; Wezi Medical Centre, Mzuzu, Malawi.
Ahmed MA; ICMR-Regional Medical Research Centre, NER, Dibrugarh, Assam, India.
Muh F; Faculty of Public Health, Department of Epidemiology and Tropical Diseases, Universitas Diponegoro, Semarang, Indonesia.
Lee SJ; Department of Obstetrics and Gynecology, Kangwon National University Hospital, Chuncheon, Gangwon-do, Republic of Korea.
Na S; Department of Obstetrics and Gynecology, Kangwon National University Hospital, Chuncheon, Gangwon-do, Republic of Korea.
Chun W; Department of Pharmacology, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Park WS; Department of Physiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
No JH; Host-Parasite Research Laboratory, Institut Pasteur Korea, Seongnam, Gyeonggi-do, Republic of Korea.
Kim MJ; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Han ET; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
Han JH; Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 09; Vol. 19 (2), pp. e0298087. Date of Electronic Publication: 2024 Feb 09 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Malaria*/parasitology
Malaria, Falciparum*/diagnosis
Malaria, Falciparum*/parasitology
Humans ; Plasmodium falciparum/genetics ; Colorimetry ; Sensitivity and Specificity ; Nucleic Acid Amplification Techniques/methods ; Molecular Diagnostic Techniques/methods
SCR Protocol:: LAMP assay

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Artificial nighttime lighting impacts Plasmodium falciparum mature stage V gametocytes infectivity in Anopheles stephensi.
Autorzy:: Llergo JL; Global Health Medicines R&D, GlaxoSmithKline, C/Severo Ochoa 2, Tres Cantos, 28760, Madrid, Spain.
Garuti H; Global Health Medicines R&D, GlaxoSmithKline, C/Severo Ochoa 2, Tres Cantos, 28760, Madrid, Spain.
Lopez C; Global Health Medicines R&D, GlaxoSmithKline, C/Severo Ochoa 2, Tres Cantos, 28760, Madrid, Spain.
Sanchez J; In Vivo Science and Delivery (IVSD), GlaxoSmithKline, C/Severo Ochoa 2, Tres Cantos, 28760, Madrid, Spain.
Calvo D; Global Health Medicines R&D, GlaxoSmithKline, C/Severo Ochoa 2, Tres Cantos, 28760, Madrid, Spain. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 08; Vol. 23 (1), pp. 42. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Anopheles*/parasitology
Malaria, Falciparum*/parasitology
Animals ; Female ; Humans ; Plasmodium falciparum ; Lighting ; Mosquito Vectors ; Oocysts

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Effectiveness of artemether-lumefantrine for treating uncomplicated malaria in low- and high-transmission areas of Ghana.
Autorzy:: Mawuli MA; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana. .; Department of Pathology, University of Ghana Medical School, College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana. .
Amoah LE; Department of Immunology, Noguchi Memorial Institute for Medical Research College of Health Sciences, University of Ghana, Legon, Accra, Ghana.
Cui L; Department of Internal Medicine, University of South Florida, 3720 Spectrum Blvd, Tampa, FL, 33612, USA.
Quashie NB; West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), College of Basic and Applied Sciences, University of Ghana, Legon, Accra, Ghana.; Department of Epidemiology, Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra, Ghana.; Centre for Tropical Clinical Pharmacology and Therapeutics, University of Ghana Medical School, University of Ghana, Korle-Bu, Accra, Ghana.
Afrane YA; Department of Medical Microbiology, University of Ghana Medical School College of Health Sciences, University of Ghana, Korle-Bu, Accra, Ghana.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 05; Vol. 23 (1), pp. 40. Date of Electronic Publication: 2024 Feb 05.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria, Falciparum*/drug therapy
Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Ghana ; Drug Combinations ; Artemether/therapeutic use ; Recurrence ; Parasitemia/drug therapy ; Ethanolamines/therapeutic use ; Fluorenes/therapeutic use ; Plasmodium falciparum/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania.
Autorzy:: Ngasala B; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Bushukatale S; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Chiduo M; National Institute for Medical Research, Tanga Research Centre, P.O Box 5004, Tanga, Tanzania.
Makene T; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Mkony L; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Mohamed A; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania.
Molteni F; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania.
Chacky F; National Malaria Control Program (NMCP), Ministry of Health, P.O. Box 743, Dar Es Salaam, Tanzania.
Njau RJA; Department of Medical Parasitology and Entomology, School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, P.O. Box 65011, Dar es Salaam, Tanzania.
Mwaiswelo R; Department of Microbiology, Immunology, and Parasitology, Faculty of Medicine, Hubert Kairuki Memorial University, P.O Box 65300, Dar es Salaam, Tanzania. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Mar 29; Vol. 23 (1), pp. 90. Date of Electronic Publication: 2024 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*
Malaria, Falciparum*/drug therapy
Artemisinins*
Malaria*/drug therapy
Child ; Humans ; Infant ; Amodiaquine ; Artesunate/therapeutic use ; Tanzania ; Plasmodium falciparum ; Drug Combinations

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs.
Autorzy:: Embo-Ibouanga AW; Aix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Nguyen M; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Paloque L; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Coustets M; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Joly JP; Aix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Augereau JM; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Vanthuyne N; Aix-Marseille University, CNRS, Centrale Marseille ISM2 Marseille, 13007 Marseille, France.
Bikanga R; Université des Sciences et Techniques de Masuku, LASNSOM, BP 901 Franceville, Gabon.
Coquin N; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.
Robert A; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.
Audran G; Aix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Boissier J; IHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 66860 Perpignan, France.
Mellet P; Magnetic Resonance of Biological Systems, UMR 5536 CNRS-University of Bordeaux, 33076 Bordeaux, France.; INSERM, 33076 Bordeaux, France.
Benoit-Vical F; LCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.; Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier (UPS), 31077 Toulouse, France.
Marque SRA; Aix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/chemistry
Cytostatic Agents*/therapeutic use
Malaria*/drug therapy
Malaria, Falciparum*/drug therapy
Humans ; Plasmodium falciparum ; Peptides/pharmacology ; Peptides/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Malaria infection among adults residing in a highly endemic region from the Democratic Republic of the Congo.
Autorzy:: Kayiba NK; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Department of Public Health, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.; Research Institute of Health and Society, Université Catholique de Louvain, Brussels, Belgium.
Nitahara Y; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Tshibangu-Kabamba E; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Department of Internal Medicine, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.
Mbuyi DK; Department of Internal Medicine, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.
Kabongo-Tshibaka A; Department of Internal Medicine, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.; Department of Molecular Infection Dynamics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.
Kalala NT; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Department of Public Health, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.
Tshiebue BM; Department of Internal Medicine, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.
Candray-Medina KS; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kaku N; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Nakagama Y; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Speybroeck N; Research Institute of Health and Society, Université Catholique de Louvain, Brussels, Belgium.
Mumba DN; Department of Parasitology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Disashi GT; Department of Internal Medicine, Faculty of Medicine - Pharmacy and Public Health, University of Mbujimayi, Mbuji Mayi, Democratic Republic of Congo.
Kaneko A; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Kido Y; Research Center for Infectious Disease Sciences, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. .; Departments of Virology and Parasitology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Mar 18; Vol. 23 (1), pp. 82. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria*/epidemiology
Malaria*/parasitology
Malaria, Falciparum*/epidemiology
Male ; Adult ; Female ; Humans ; Democratic Republic of the Congo/epidemiology ; Cross-Sectional Studies ; Plasmodium falciparum ; Plasmodium malariae ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Role for gene conversion in the evolution of cell-surface antigens of the malaria parasite Plasmodium falciparum.
Autorzy:: Letcher B; EMBL-EBI, Hinxton, United Kingdom.; Laboratory of Biology and Modelling of the Cell, CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Maciuca S; Genomics England, London, United Kingdom.
Iqbal Z; EMBL-EBI, Hinxton, United Kingdom.; Pokaż więcej
Źródło:: PLoS biology [PLoS Biol] 2024 Mar 07; Vol. 22 (3), pp. e3002507. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Parasites*/metabolism
Malaria*/parasitology
Hominidae*
Malaria, Falciparum*
Animals ; Humans ; Plasmodium falciparum/metabolism ; Gene Conversion ; Antigens, Surface ; Protozoan Proteins/genetics ; Protozoan Proteins/metabolism ; Genetic Variation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Evaluating evidence for co-geography in the Anopheles-Plasmodium host-parasite system.
Autorzy:: Rehmann CT; Institute of Ecology and Evolution and Department of Biology, University of Oregon, Eugene 97403, USA.
Ralph PL; Institute of Ecology and Evolution and Department of Biology, University of Oregon, Eugene 97403, USA.; Department of Mathematics, University of Oregon, Eugene 97403, USA.
Kern AD; Institute of Ecology and Evolution and Department of Biology, University of Oregon, Eugene 97403, USA.; Pokaż więcej
Źródło:: G3 (Bethesda, Md.) [G3 (Bethesda)] 2024 Mar 06; Vol. 14 (3).
Typ publikacji:: Journal Article
MeSH Terms:: Parasites*/genetics
Anopheles*/genetics
Anopheles*/parasitology
Plasmodium*/genetics
Malaria, Falciparum*
Animals ; Host-Parasite Interactions/genetics ; Plasmodium falciparum/genetics ; Geography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine.
Autorzy:: Ma R; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Salinas ND; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Orr-Gonzalez S; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Richardson B; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Ouahes T; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Torano H; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Jenkins BJ; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Dickey TH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Neal J; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Duan J; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Morrison RD; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Gittis AG; Structural Biology Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Doritchamou JYA; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Zaidi I; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Lambert LE; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Duffy PE; Vaccine Development Unit, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Pathogenesis and Immunity Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Tolia NH; Host-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2024 Mar 04; Vol. 20 (3), pp. e1011879. Date of Electronic Publication: 2024 Mar 04 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Malaria Vaccines*
Malaria, Falciparum*/parasitology
Malaria*
Humans ; Pregnancy ; Female ; Placenta/metabolism ; Antibodies, Protozoan ; Plasmodium falciparum/metabolism ; Antigens, Protozoan ; Chondroitin Sulfates/metabolism ; Erythrocytes/parasitology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Atypical memory B cell frequency correlates with antibody breadth and function in malaria immune adults.
Autorzy:: Partey FD; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. .
Dowuona JNN; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Pobee ANA; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Walker MR; Centre for Medical Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Aculley B; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Prah DA; West African Centre for Cell Biology of Infectious Pathogens, University of Ghana, Legon, Ghana.
Ofori MF; Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.
Barfod LK; Centre for Medical Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4888. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria, Falciparum*/epidemiology
Malaria*
Adult ; Animals ; Humans ; Memory B Cells ; Antigens, Protozoan ; Antibodies, Protozoan ; Plasmodium falciparum ; Merozoites ; Protozoan Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Trend analysis of malaria surveillance data in West Wallaga, West Oromia, Ethiopia: a framework for planning and elimination.
Autorzy:: Tesfaye S; Department of Public Health, Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia. .
Yesuf A; Department of Public Health, Saint Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 21; Vol. 23 (1), pp. 52. Date of Electronic Publication: 2024 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria*/epidemiology
Malaria, Vivax*/parasitology
Malaria, Falciparum*/parasitology
Humans ; Ethiopia/epidemiology ; Cross-Sectional Studies ; Retrospective Studies ; Plasmodium vivax ; Plasmodium falciparum ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia.
Autorzy:: Grimée M; Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France. .; Collège Doctoral, Sorbonne Université, Paris, France. .
Tacoli C; Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Sandfort M; Collège Doctoral, Sorbonne Université, Paris, France.; Malaria Parasites and Hosts, Institut Pasteur, Université Paris Cité, Paris, France.
Obadia T; Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France.; Bioinformatics and Biostatistics Hub, Institut Pasteur, Université Paris Cité, Paris, France.
Taylor AR; Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France.
Vantaux A; Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
Robinson LJ; Burnet Institute, Melbourne, Australia.; Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.; Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Lek D; National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.; School of Public Health, National Institute of Public Health, Phnom Penh, Cambodia.
Longley RJ; Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, Australia.
Mueller I; Malaria Parasites and Hosts, Institut Pasteur, Université Paris Cité, Paris, France.; Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.; National Centre for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Popovici J; Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
White MT; Infectious Disease Epidemiology and Analytics, Institut Pasteur, Université Paris Cité, Paris, France. .; Malaria Parasites and Hosts, Institut Pasteur, Université Paris Cité, Paris, France. .
Witkowski B; Malaria Research Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. .; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Feb 15; Vol. 23 (1), pp. 49. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Journal Article
MeSH Terms:: Malaria, Falciparum*/epidemiology
Malaria*/diagnosis
Malaria*/epidemiology
Malaria, Vivax*/diagnosis
Malaria, Vivax*/epidemiology
Adult ; Humans ; Male ; Plasmodium falciparum ; Plasmodium vivax ; Cambodia/epidemiology ; Incidence ; Cross-Sectional Studies ; Forests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""falciparum"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji